Healthcare, Pharma & Life Sciences

MemorialCare's Long Beach, Saddleback Hospitals Earn AHA Stroke Gold Plus Awards

Image
MemorialCare's Long Beach, Saddleback Hospitals Earn AHA Stroke Gold Plus Awards

Fountain Valley, Calif. – September 21, 2026 -- MemorialCare's Long Beach Medical Center and Saddleback Medical Center have received the American Heart Association's Get With The Guidelines® - Stroke Gold Plus quality achievement award, recognizing stroke treatment aligned with nationally validated clinical guidelines. Long Beach Medical Center additionally earned the Get With The Guidelines® - Heart Failure Gold Plus award for reducing readmissions and increasing healthy days at home for heart failure patients.

Long Beach Medical Center collects four additional Target Honor Roll designations

Long Beach Medical Center received the Target: Stroke Honor Roll Elite Plus, Advanced Therapy, Target: Type 2 Diabetes Honor Roll, and Target: Heart Failure Honor Roll Optimal. Saddleback Medical Center secured the Target: Stroke Honor Roll Elite Plus and Target: Type 2 Diabetes Honor Roll designations.

RPM Market to Nearly Double to $62.2B by 2031, Wissen Research Finds

Image
RPM Market to Nearly Double to $62.2B by 2031, Wissen Research Finds

Sheridan, Wyoming – September 21, 2026 -- The global remote patient monitoring (RPM) market is set to grow from $34.5 billion in 2026 to $62.2 billion by 2031, a 12.5% compound annual growth rate, according to a new study by Wissen Research.

Reimbursement codes and readmission penalties push hospitals toward RPM at scale

Dedicated CMS billing codes are giving U.S. providers a recurring revenue incentive to deploy RPM, while health systems use the technology to avoid costly 30-day readmission penalties tied to chronic disease relapse. Cardiovascular disease held the largest application share in 2025, reflecting the clinical and financial burden of heart failure, atrial fibrillation and hypertension.

Project Healthy Minds Sets Oct. 8-10 NYC Gala, Festival; Nespresso Honored

Image
Project Healthy Minds Sets Oct. 8-10 NYC Gala, Festival; Nespresso Honored

New York – September 21, 2026 -- Project Healthy Minds, a mental health tech nonprofit, will host its fourth annual World Mental Health Day Gala on Thursday, October 8, and its fifth annual World Mental Health Day Festival on Saturday, October 10, both at New York's Spring Studios. The nonprofit says its programmatic initiatives have already served more than 500,000 people, with a goal of connecting over 10 million Americans to mental health services over the next decade.

Invictus Pharmacy Earns LegitScript Merchant Certification

Image
Invictus Pharmacy Earns LegitScript Merchant Certification

New York – September 21, 2026 -- Invictus Pharmacy has secured LegitScript Healthcare Merchant Certification for its platform InvictusPharmacy.com, joining a select group of digital pharmacy operators that includes Amazon Pharmacy in meeting the certifier's compliance standards.

LegitScript certification confirms pharmacy licensing and prescription validity standards

The certification evaluates pharmacy licensing, regulatory compliance, patient privacy protocols, valid prescription practices, website transparency and advertising conduct. Invictus Pharmacy's approval places it among established platforms cleared to operate within the regulated digital healthcare marketplace.

AAKP Praises HHS Task Force Picks After Years of Kidney Screening Delay

Image
AAKP Praises HHS Task Force Picks After Years of Kidney Screening Delay

Washington – September 21, 2026 -- The American Association of Kidney Patients (AAKP) has endorsed Health and Human Services Secretary Robert F. Kennedy Jr.'s new appointments to the U.S. Preventive Services Task Force (USPSTF), following a years-long campaign by the group to force reforms on kidney disease screening policy. AAKP President Edward V. Hickey III said the appointees bring the diverse credentials needed to advance patient-centered medicine after what the organization calls two decades of Task Force inaction on kidney health.

LaserAway Opens 231st Clinic, Marks 20 Years Without a Closure

Image
LaserAway Opens 231st Clinic, Marks 20 Years Without a Closure

Los Angeles – September 21, 2026 -- LaserAway has opened its 231st U.S. location in Visalia, California, at 3413 S Mooney Blvd, Unit 101, marking two decades of operation without a single clinic closure.

LaserAway marks 20th anniversary with zero clinic closures since 2006 launch

The Visalia opening coincides with the company's 20th anniversary, a milestone the privately owned, franchise-free operator says is rare in both retail and medical aesthetics. LaserAway was founded in 2006 by Dr. Roy Winston alongside brothers Scott, Brock and Todd Heckmann, starting from a single clinic on Sunset Boulevard in West Hollywood, California.

FDA Grants Full Approval to Lilly's Inluriyo-Verzenio Combo for Breast Cancer

Image
FDA Grants Full Approval to Lilly's Inluriyo-Verzenio Combo for Breast Cancer

Indianapolis – September 21, 2026 -- The U.S. Food and Drug Administration has granted full approval to Eli Lilly and Company's (NYSE: LLY) Inluriyo (imlunestrant) in combination with Verzenio (abemaciclib) for adults with estrogen receptor-positive (ER+), HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer whose disease progressed after at least one line of endocrine therapy.

EMBER-3 trial shows combination doubles progression-free survival

The approval rests on Phase 3 EMBER-3 data in 159 patients with ESR1-mutated metastatic breast cancer who had previously received an aromatase inhibitor, with or without a CDK4/6 inhibitor. Patients randomized to Inluriyo plus Verzenio (n=67) achieved a median progression-free survival of 11.1 months, versus 5.5 months for Inluriyo alone (n=92), a hazard ratio of 0.53 (95% CI, 0.35–0.80).

San Juan Regional Cuts Bed-Assignment Time 38.9% With Oracle Health Tools

Image
San Juan Regional Cuts Bed-Assignment Time 38.9% With Oracle Health Tools

Austin, Texas – September 21, 2026 -- San Juan Regional Medical Center has cut bed-assignment time by 38.9%, from 54.00 minutes to 33.00 minutes, one month after deploying new Oracle Health operational solutions, according to figures released by Oracle.

Environmental services response time drops 48.5% after go-live

The Farmington, New Mexico-based nonprofit health system, which serves the Four Corners region spanning New Mexico, Arizona, Colorado, and Utah, reported environmental services response time fell 48.5%, from 49.67 minutes to 25.56 minutes, surpassing its internal target. Clean-completion time for environmental services improved 1.2% and continues trending positively, the organization said.

INCMNSZ Becomes First Mexican National Health Institute AAHRPP-Accredited

Image
INCMNSZ Becomes First Mexican National Health Institute AAHRPP-Accredited

Mexico City – September 21, 2026 -- The Association for the Accreditation of Human Research Protection Programs (AAHRPP) has awarded full accreditation to Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMNSZ), making it the first of Mexico's 13 National Institutes of Health under the Mexican Ministry of Health to reach this status.

INCMNSZ becomes only the second organization in Mexico to earn AAHRPP accreditation, joining a global roster that now exceeds 600 accredited entities. AAHRPP separately confirmed reaccreditation for five additional organizations, underscoring continued renewal activity within its existing accredited network.

BioCytics Taps Eremid Genomics to Sequence Cancer Cell Therapy

Image
BioCytics Taps Eremid Genomics to Sequence Cancer Cell Therapy

Huntersville, N.C. – September 21, 2026 -- BioCytics, Inc. has engaged Eremid Genomic Services to perform single cell transcriptomic and TCR sequencing analysis on immune cells central to its autologous cancer cell therapy program.

Eremid will characterize immune precursor cells before clinical deployment

The North Carolina-based genomics contract research organization will run scRNA-Seq and TCR sequencing on an autologous immune cell fraction supplied by BioCytics. The analysis is designed to confirm whether expanded immune cells are biologically fit for cancer-killing activity and to map their mechanism of action ahead of reinfusion into patients.